Skip to main content
Log in

Geraniol attenuates osteoclast differentiation by suppressingNF-kB activity and expression of osteoclastogenic genes

  • Original Research
  • Published:
Medicinal Chemistry Research Aims and scope Submit manuscript

Abstract

Osteoporotic patients have lower bone mass due to increased bone resorption by osteoclasts. The aim of this study was to investigate the cytotoxic and anti-osteoclastogenic effects of geraniol, a natural monoterpene on human CD14+ monocytes (ex vivo) and murine RAW264.7 macrophages (in vitro) using alamar blue and tartrate resistant acid phosphatase staining respectively. The anti-osteoclastogenic activity of geraniol was further explored by analyzing its effects on actin ring formation and bone resorptive function of osteoclasts. Geraniol significantly (p < 0.001) inhibited osteoclast formation in CD14+ monocytes and RAW264.7 macrophages without cytotoxicity. Moreover, reduced osteoclastogenesis in these cells led to an arrest in actin ring formation and diminished bone resorption. Analysis of underlying molecular mechanisms revealed that geraniol alleviated NF-kB activity, an indispensable upstream modulator of osteoclast formation. Furthermore, expression of key osteoclastogenic genes such as dendritic cell-specific transmembrane protein (DC-STAMP) involved in cell-cell fusion and nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 (NFATc1), a master transcription factor essential for osteoclast differentiation was downregulated by geraniol. These observations indicate that inhibition of osteoclast differentiation is presumably one of the pharmacological properties of geraniol.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337–342

    Article  CAS  PubMed  Google Scholar 

  • Chen W, Viljoen AM (2010) Geraniol—a review of a commercially important fragrance material. S Afr J Bot 76:643–651

    Article  CAS  Google Scholar 

  • Costa AG, Cusano NE, Silva BC, Cremers S, Bilezikian JP (2011) Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis. Nat Rev Rheumatol 7:447–456

    Article  CAS  PubMed  Google Scholar 

  • Cote GM (2015) Rank ligand as a target in musculoskeletal neoplasms. Curr Rev Musculoskelet Med 8:339–343

    Article  PubMed  PubMed Central  Google Scholar 

  • Dai S, Hirayama T, Abbas S, Abu-Amer Y (2004) The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis. J Biol Chem 279:37219–37222

    Article  CAS  PubMed  Google Scholar 

  • Deepak V, Kasonga A, Kruger MC, Coetzee M (2015a) Inhibitory effects of eugenol on RANKL-induced osteoclast formation via attenuation of NF-kappaB and MAPK pathways. Connect Tissue Res 56:195–203

    Article  CAS  PubMed  Google Scholar 

  • Deepak V, Kruger MC, Joubert A, Coetzee M (2015b) Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis. Biofactors 41:403–413

    CAS  PubMed  Google Scholar 

  • Delaisse JM, Andersen TL, Engsig MT, Henriksen K, Troen T, Blavier L (2003) Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities. Microsc Res Tech 61:504–513

    Article  CAS  PubMed  Google Scholar 

  • Dias DA, Urban S, Roessner U (2012) A historical overview of natural products in drug discovery. Metabolites 2:303–336

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Drake MT, Clarke BL, Lewiecki EM (2015) The pathophysiology and treatment of osteoporosis. Clin Ther 37:1837–1850

    Article  CAS  PubMed  Google Scholar 

  • Ek-Rylander B, Flores M, Wendel M, Heinegard D, Andersson G (1994) Dephosphorylation of osteopontin and bone sialoprotein by osteoclastic tartrate-resistant acid phosphatase. Modulation of osteoclast adhesion in vitro. J Biol Chem 269:14853–14856

    CAS  PubMed  Google Scholar 

  • Feng R, Anderson G, Xiao G, Elliott G, Leoni L, Mapara MY, Roodman GD, Lentzsch S (2007) SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-kappaB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth. Blood 109:2130–2138

    Article  CAS  PubMed  Google Scholar 

  • Fonseca D, Ward WE (2004) Daidzein together with high calcium preserve bone mass and biomechanical strength at multiple sites in ovariectomized mice. Bone 35:489–497

    Article  CAS  PubMed  Google Scholar 

  • Hadjidakis DJ, Androulakis II (2006) Bone remodeling. Ann N Y Acad Sci 1092:385–396

    Article  CAS  PubMed  Google Scholar 

  • Hayman AR (2008) Tartrate-resistant acid phosphatase (TRAP) and the osteoclast/immune cell dichotomy. Autoimmunity 41:218–223

    Article  CAS  PubMed  Google Scholar 

  • Iotsova V, Caamano J, Loy J, Yang Y, Lewin A, Bravo R (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med 3:1285–1289

    Article  CAS  PubMed  Google Scholar 

  • Kim SH, Bae HC, Park EJ, Lee CR, Kim BJ, Lee S, Park HH, Kim SJ, So I, Kim TW, Jeon JH (2011) Geraniol inhibits prostate cancer growth by targeting cell cycle and apoptosis pathways. Biochem Biophys Res Commun 407:129–134

    Article  CAS  PubMed  Google Scholar 

  • McGrath EE (2011) OPG/RANKL/RANK pathway as a therapeutic target in cancer. J Thorac Oncol 6:1468–1473

    Article  PubMed  Google Scholar 

  • Medicherla K, Sahu BD, Kuncha M, Kumar JM, Sudhakar G, Sistla R (2015) Oral administration of geraniol ameliorates acute experimental murine colitis by inhibiting pro-inflammatory cytokines and NF-kappaB signaling. Food Funct 6:2984–2995

    Article  CAS  PubMed  Google Scholar 

  • Mundy GR (1999) Bone Remodelling and its Disorders. Taylor & Francis, London

    Google Scholar 

  • Ortega N, Behonick D, Stickens D, Werb Z (2003) How proteases regulate bone morphogenesis. Ann N Y Acad Sci 995:109–116

    Article  CAS  PubMed  Google Scholar 

  • Singh B, Sharma RA (2015) Plant terpenes: defense responses, phylogenetic analysis, regulation and clinical applications. 3 Biotech 5:129–151

    Article  Google Scholar 

  • Soysa NS, Alles N (2009) NF-kappaB functions in osteoclasts. Biochem Biophys Res Commun 378:1–5

    Article  CAS  PubMed  Google Scholar 

  • Strait K, Li Y, Dillehay DL, Weitzmann MN (2008) Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency. Int J Mol Med 21:521–525

    CAS  PubMed  Google Scholar 

  • Takayanagi H (2007) The role of NFAT in osteoclast formation. Ann N Y Acad Sci 1116:227–237

    Article  CAS  PubMed  Google Scholar 

  • Tat SK, Pelletier JP, Velasco CR, Padrines M, Martel-Pelletier J (2009) New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target? Keio J Med 58:29–40

    Article  CAS  PubMed  Google Scholar 

  • Tsai ML, Lin CC, Lin WC, Yang CH (2011) Antimicrobial, antioxidant, and anti-inflammatory activities of essential oils from five selected herbs. Biosci Biotechnol Biochem 75:1977–1983

    Article  CAS  PubMed  Google Scholar 

  • Uchiyama S, Yamaguchi M (2005) Beta-cryptoxanthin stimulates cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J Cell Biochem 95:1224–1234

    Article  CAS  PubMed  Google Scholar 

  • Vaira S, Alhawagri M, Anwisye I, Kitaura H, Faccio R, Novack DV (2008a) RelA/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J Clin Invest 118:2088–2097

    CAS  PubMed  PubMed Central  Google Scholar 

  • Vaira S, Johnson T, Hirbe AC, Alhawagri M, Anwisye I, Sammut B, O’Neal J, Zou W, Weilbaecher KN, Faccio R, Novack DV (2008b) RelB is the NF-kappaB subunit downstream of NIK responsible for osteoclast differentiation. Proc Natl Acad Sci U S A 105:3897–3902

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Visagie A, Kasonga A, Deepak V, Moosa S, Marais S, Kruger MC, Coetzee M (2015) Commercial honeybush (Cyclopia spp.) tea extract inhibits osteoclast formation and bone resorption in RAW264.7 Murine macrophages-an in vitro Study. Int J Environ Res Public Health 12:13779–13793

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wada T, Nakashima T, Hiroshi N, Penninger JM (2006) RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 12:17–25

    Article  CAS  PubMed  Google Scholar 

  • Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N, Morita K, Ninomiya K, Suzuki T, Miyamoto K, Oike Y, Takeya M, Toyama Y, Suda T (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202:345–351

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yamaguchi M, Weitzmann MN (2009) The estrogen 17beta-estradiol and phytoestrogen genistein mediate differential effects on osteoblastic NF-kappaB activity. Int J Mol Med 23:297–301

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by grants from the University of Pretoria Vice Chancellor’s Postdoctoral Research Fellowship; RESCOM, University of Pretoria and the University of Pretoria’s Strategic Institutional Research Theme in Food, Nutrition, and Well-being.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Magdalena Coetzee.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the Human Research Ethics Committee of the Faculty of Health Sciences, University of Pretoria (Protocol approval number: 67/2014) and with the 1964 Helsinki declaration and its later amendments. Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deepak, V., Kruger, M.C. & Coetzee, M. Geraniol attenuates osteoclast differentiation by suppressingNF-kB activity and expression of osteoclastogenic genes. Med Chem Res 26, 19–26 (2017). https://doi.org/10.1007/s00044-016-1715-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00044-016-1715-7

Keywords

Navigation